SALT LAKE CITY, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal first-quarter...查看全文
一年交易一次2018-08-21 21:59
$万基遗传(MYGN)$ 计划于北京时间 2018-08-22 04:30(2018/08/21 16:30 EDT)举行 2018 财年 Q4 财报电话会议。
Myriad Genetics, Inc.是一家领先的分子诊断公司,致力于通过该评估发展中国家疾病的人员的风险转化试验的发现及商业化,为患者的生活带来改变,指导治疗决策和评估疾病进展和复发...查看全文
路过十八次2018-06-02 11:03
昨夜美股大涨,医疗板块表现最凶猛,海外市场对于基因测序,分子诊断,创新药类标的的追捧也不是吹的,$百济神州(BGNE)$来自我国本土的医药研发公司已经是新高再新高了,$万基遗传(MYGN)$ 主要是基因测序,分子诊断和基因药物研发,最近也爆发了,其分子诊断这一块主要涉及肿瘤标志物的检测,基因...查看全文
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027520 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027334 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027333 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027327 Size: 3 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027328 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027329 Size: 5 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027332 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-027331 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 8-K Current report, item 5.07 Accession Number: 0000899923-24-000028 Act: 34 Size: 196 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001238403-24-000002 Size: 6 KB 网页链接